Search

Search Constraints

You searched for: Author/Creator Varón, Adriana

Search Results

1. Decompensated cirrhosis and liver transplantation negatively impact in DAA treatment response: Real‐world experience from HCV‐LALREAN cohort. Issue 12 (13th August 2020)

2. Direct‐Acting Antivirals and Hepatocellular Carcinoma: No Evidence of Higher Wait‐List Progression or Posttransplant Recurrence. Issue 5 (21st April 2020)

3. Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy. (9th December 2018)

4. Liver transplantation for hepatocellular carcinoma: evaluation of the alpha‐fetoprotein model in a multicenter cohort from Latin America. (15th June 2016)

5. Liver transplantation for hepatocellular carcinoma: impact of expansion criteria in a multicenter cohort study from a high waitlist mortality region. (7th January 2021)

7. Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV‐infected patients in a real‐life cohort from Latin America. Issue 9 (6th June 2017)

8. Performance of pre‐transplant criteria in prediction of hepatocellular carcinoma progression and waitlist dropout. (2nd April 2022)

9. Recurrence of hepatocellular carcinoma after liver transplantation: Prognostic and predictive factors of survival in a Latin American cohort. (2nd December 2020)

10. Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma. (4th February 2019)